Fig. 2
From: Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
Kaplan-Meier survival curves of disease-specific survival stratified by residual disease. a Comparison of high-grade serous carcinoma (HGSC) with different amounts of RD (none = 206, < 1 cm = 230, suboptimal = 347). b Comparison of endometrioid carcinoma (EC) with different amounts of RD. (none = 119, < 1 cm = 29, suboptimal = 10) (c). Comparison of clear cell carcinoma (CCC) with different amounts of RD (none = 93, < 1 cm = 26, suboptimal = 17). d Comparison of low-grade serous carcinoma (LGSC) with different amounts of RD (none = 16, < 1 cm = 21, suboptimal = 27). Significance (p) is indicated by log-rank